110 related articles for article (PubMed ID: 17657172)
21. Decreased expression of claudin-1 in rectal cancer: a factor for recurrence and poor prognosis.
Yoshida T; Kinugasa T; Akagi Y; Kawahara A; Romeo K; Shiratsuchi I; Ryu Y; Gotanda Y; Shirouzu K
Anticancer Res; 2011 Jul; 31(7):2517-25. PubMed ID: 21873169
[TBL] [Abstract][Full Text] [Related]
22. SPARCL1 expression increases with preoperative radiation therapy and predicts better survival in rectal cancer patients.
Kotti A; Holmqvist A; Albertsson M; Sun XF
Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1196-202. PubMed ID: 24661672
[TBL] [Abstract][Full Text] [Related]
23. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy.
Lindebjerg J; Spindler KL; Ploen J; Jakobsen A
Colorectal Dis; 2009 Mar; 11(3):264-9. PubMed ID: 18573119
[TBL] [Abstract][Full Text] [Related]
24. [Expression and clinical significance of Mucin and E-cadherin in colorectal tumors].
Yu XW; Rong W; Xu FL; Xu GY; Sun YR; Feng MY
Ai Zheng; 2007 Nov; 26(11):1204-10. PubMed ID: 17991319
[TBL] [Abstract][Full Text] [Related]
25. Postoperative radiotherapy for stage IIIA rectal cancer: is it justified?
Kariv Y; Kariv R; Hammel JP; Lavery IC
Dis Colon Rectum; 2008 Oct; 51(10):1459-66. PubMed ID: 18661186
[TBL] [Abstract][Full Text] [Related]
26. Optimal surgery time after preoperative chemoradiotherapy for locally advanced rectal cancers.
Lim SB; Choi HS; Jeong SY; Kim DY; Jung KH; Hong YS; Chang HJ; Park JG
Ann Surg; 2008 Aug; 248(2):243-51. PubMed ID: 18650634
[TBL] [Abstract][Full Text] [Related]
27. Can depth of tumour invasion predict lymph node positivity in patients undergoing resection for early rectal cancer? A comparative study between T1 and T2 cancers.
Rasheed S; Bowley DM; Aziz O; Tekkis PP; Sadat AE; Guenther T; Boello ML; McDonald PJ; Talbot IC; Northover JM
Colorectal Dis; 2008 Mar; 10(3):231-8. PubMed ID: 18257848
[TBL] [Abstract][Full Text] [Related]
28. Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas.
Li M; Li JY; Zhao AL; Gu J
Oncology; 2007; 73(1-2):52-7. PubMed ID: 18334831
[TBL] [Abstract][Full Text] [Related]
29. Effect of adjuvant radiotherapy on local recurrence in stage II rectal cancer.
Park IJ; Kim HC; Yu CS; Kim TW; Jang SJ; Kim JC
Ann Surg Oncol; 2008 Feb; 15(2):519-25. PubMed ID: 17960464
[TBL] [Abstract][Full Text] [Related]
30. High MMP-1 mRNA expression is a risk factor for disease-free and overall survivals in patients with invasive breast carcinoma.
Cheng S; Tada M; Hida Y; Asano T; Kuramae T; Takemoto N; Hamada J; Miyamoto M; Hirano S; Kondo S; Moriuchi T
J Surg Res; 2008 May; 146(1):104-9. PubMed ID: 17663001
[TBL] [Abstract][Full Text] [Related]
31. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E
Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327
[TBL] [Abstract][Full Text] [Related]
32. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
[TBL] [Abstract][Full Text] [Related]
33. Regional control of melanoma neck node metastasis after selective neck dissection with or without adjuvant radiotherapy.
Hamming-Vrieze O; Balm AJ; Heemsbergen WD; Hooft van Huysduynen T; Rasch CR
Arch Otolaryngol Head Neck Surg; 2009 Aug; 135(8):795-800. PubMed ID: 19687401
[TBL] [Abstract][Full Text] [Related]
34. [Lateral pelvic metastasis and micrometastasis in low rectal cancer].
Wang C; Zhou ZG; Yu YY; Li Y; Yang L; Cheng Z; Lei WZ
Zhonghua Wai Ke Za Zhi; 2007 Sep; 45(17):1160-3. PubMed ID: 18067705
[TBL] [Abstract][Full Text] [Related]
35. Epithelial human leukocyte antigen-DR expression predicts reduced recurrence rates and prolonged survival in rectal cancer patients.
de Bruin EC; van de Velde CJ; van Krieken JH; Marijnen CA; Medema JP
Clin Cancer Res; 2008 Feb; 14(4):1073-9. PubMed ID: 18281539
[TBL] [Abstract][Full Text] [Related]
36. Fascin overexpression correlates with positive thrombospondin-1 and syndecan-1 expressions and a more aggressive clinical course in patients with gallbladder cancer.
Roh YH; Kim YH; Choi HJ; Lee KE; Roh MS
J Hepatobiliary Pancreat Surg; 2009; 16(3):315-21. PubMed ID: 19259612
[TBL] [Abstract][Full Text] [Related]
37. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
[TBL] [Abstract][Full Text] [Related]
38. [Prognostic analysis of middle and lower rectal cancer with different degrees of infiltration in mesorectum].
Zhuo HQ; Zhou YB; Lü L; Zhou J; Yang WY; Li YJ
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(12):820-2. PubMed ID: 19595121
[TBL] [Abstract][Full Text] [Related]
39. Treatment of esophageal cancer based on histology: a surveillance epidemiology and end results analysis.
Chang DT; Chapman C; Shen J; Su Z; Koong AC
Am J Clin Oncol; 2009 Aug; 32(4):405-10. PubMed ID: 19415029
[TBL] [Abstract][Full Text] [Related]
40. Number and size of lymph nodes recovered from dukes B rectal cancers: correlation with prognosis and histologic antitumor immune response.
Murphy J; Pocard M; Jass JR; O'Sullivan GC; Lee G; Talbot IC
Dis Colon Rectum; 2007 Oct; 50(10):1526-34. PubMed ID: 17828403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]